Items where authors include "Jackson, S."

Article

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Sandercock, P., Darbyshire, J., DeMets, D. et al. (2050 more authors) (2024) Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Nature Communications, 15. 924. ISSN 2041-1723

Munir, T., Cairns, D.A. orcid.org/0000-0002-2338-0179, Bloor, A. et al. (29 more authors) (2023) Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease. New England Journal of Medicine. ISSN 0028-4793

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology. ISSN 2213-8587

Anderson, M.A., Bennett, R. orcid.org/0000-0003-4037-4536, Badoux, X. et al. (22 more authors) (2023) Chronic lymphocytic leukaemia Australasian consensus practice statement. Internal Medicine Journal, 53 (9). pp. 1678-1691. ISSN 1444-0903

Hillmen, P., Pitchford, A., Bloor, A. et al. (29 more authors) (2023) Ibrutinib and rituximab versus fludarabine, cyclophosphamide, and rituximab for patients with previously untreated chronic lymphocytic leukaemia (FLAIR): interim analysis of a multicentre, open-label, randomised, phase 3 trial. Lancet Oncology, 24 (5). pp. 535-552. ISSN 1470-2045

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet. ISSN 0140-6736

Meng, B., Abdullahi, A., Ferreira, I.A.T.M. et al. (219 more authors) (2022) Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity. Nature, 603 (7902). pp. 706-714. ISSN 0028-0836

Mlcochova, P., Kemp, S.A., Dhar, M.S. et al. (258 more authors) (2021) SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion. Nature, 599. pp. 114-119. ISSN 0028-0836

Wong, M.S. and Jackson, S. (2021) Investigating the nature of expectations and its influence on attitudes towards Malaysian government e-services. International Journal of Electronic Government Research, 17 (1). pp. 31-47. ISSN 1548-3886

Jackson, S. (2021) Exploring the use and adoption of workplace automation through metaphors: a discourse dynamics analysis. Communications of the Association for Information Systems, 49 (1). pp. 86-109. ISSN 1529-3181

Ramasamy, M.N., Minassian, A.M., Ewer, K.J. et al. (418 more authors) (2020) Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial. The Lancet, 396 (10267). pp. 1979-1993. ISSN 0140-6736

Grindell, C., Tod, A. orcid.org/0000-0001-6336-3747, Bec, R. et al. (13 more authors) (2020) Using creative co-design to develop a decision support tool for people with malignant pleural effusion. BMC Medical Informatics and Decision Making, 20 (1). 179. ISSN 1472-6947

Jackson, S., Vanteeva, N. and Fearon, C. (2019) An investigation of the impact of data breach severity on the readability of mandatory data breach notification letters: evidence from U.S. firms. Journal of the Association for Information Science and Technology, 70 (11). pp. 1277-1289. ISSN 2330-1635

Fearon, C., Nachmias, S., McLaughlin, H. et al. (1 more author) (2018) Personal values, social capital, and higher education student career decidedness: a new ‘protean’-informed model. Studies in Higher Education, 43 (2). pp. 269-291. ISSN 0307-5079

Jackson, S. and Wong, M.S. (2017) A cultural theory analysis of e-government: Insights from a local government council in Malaysia. Information Systems Frontiers, 19 (6). pp. 1391-1405. ISSN 1387-3326

Font-Palma, C., Errey, O., Corden, C. et al. (8 more authors) (2016) Integrated oxyfuel power plant with improved CO2 separation and compression technology for EOR application. Process Safety and Environmental Protection, 103 (Part B). pp. 455-465. ISSN 0957-5820

Iyer, A. orcid.org/0000-0001-7788-6709, Jetten, J., Branscombe, N.R. et al. (2 more authors) (2014) The difficulty of recognising less obvious forms of group-based discrimination. Group Processes and Intergroup Relations, 17 (5). pp. 577-589. ISSN 1368-4302

Hall, D.P., MacCormick, I.J.C., Phythian-Adams, A.T. et al. (10 more authors) (2014) Network Analysis Reveals Distinct Clinical Syndromes Underlying Acute Mountain Sickness. PLoS ONE, 9 (1). e81229. ISSN 1932-6203

Reese, D.R., Thompson, M.J., MacGregor, K.B. et al. (3 more authors) (2009) Mode identification in rapidly rotating stars. Astronomy & Astrophysics, 506 (1). pp. 183-188. ISSN 0004-6361

Hutchings, H.A., Upton, P., Cheung, W.Y. et al. (6 more authors) (2008) Development of a parent version of the Manchester-Minneapolis quality of life survey for use by parents and carers of UK children: MMQL-UK (PF). Health and Quality of Life Outcomes, 6. 19. ISSN 1477-7525

Jackson, S. and Rees, A. (2007) The appalling appeal of nature: the popular influence of evolutionary psychology as a problem for sociology. Sociology, 41 (5). pp. 917-930. ISSN 0038-0385

Jackson, S. (2006) Gender, sexuality and heterosexuality: the complexity (and limits) of heteronormativity. Feminist Theory, 7 ( 1). pp. 105-121. ISSN 1464-7001

Jackson, S. and Scott, S. (2004) Sexual antinomies in late modernity. Sexualities, 7 (2). pp. 233-248. ISSN 1363-4607

Jackson, S. (2001) Why a materialist feminism is still possible (and necessary). Women's Studies International Forum, 24 ( 3-4). pp. 283-293. ISSN 0277-5395

Proceedings Paper

Rawstron, A., Webster, N., Dalal, S. et al. (15 more authors) (2023) Using Peripheral Blood (PB) Measurable Residual Disease (MRD) Levels to Predict <0.01% Bone Marrow Disease (BM uMRD4): Identification of Effective PB Targets for CLL Treatment Cessation in the Ibrutinib+Venetoclax Arm of the FLAIR Trial. In: Blood. 65th ASH: Annual Meeting & Exposition, 09-12 Dec 2023, San Diego, USA. American Society of Hematology , p. 632.